The Role of Iron Deficiency in Anemia Management: Key Controversies

ASN Renal Week Official Symposium. November, 2005
Diagnosis: Beyond Ferritin and Tranferrin Saturation
Jay B. Wish, MD

Iron Preparations: Comparisons and Consequences
Richard A. Zager, MD

Iron and Morbidity/Mortality in CKD Patients.
Kamyar Kalantar-Zadeh, MD, PhD, MPH, FASN
Toxic Effects of Iron: IV and Oral Preparations.
Rajiv Agarwal, MBBS, MD, FAHA, FASN
Panel Discussion
Drs. Wish, Zager, Kalantar-Zadeh, and Agarwal



  
Jay B. Wish, MD
Professor of Medicine at Case Western Reserve University in Cleveland, Ohio; Medical Director of Hemodialysis Services at University Hospitals of Cleveland.

Richard A. Zager, MD
Fred Hutchinson Cancer Research Center, Clinical Research Division; Head of Nephrology, University of Washington School of Medicine.

Kamyar Kalantar-Zadeh, MD, PhD, MPH, FASN
Assistant Professor of Medicine and Pediatrics at the UCLA David Geffen School of Medicine; Director, Off-Campus Dialysis Expansion Program and Epidemiology Division, Nephrology and Hypertension, Harbor-UCLA Medical Center.

Rajiv Agarwal, MBBS, MD, FAHA, FASN
Associate Professor of Clinical Medicine at Indiana University and Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana.



This group of talks is accredited for up to 2.0 AMA PRA Category 1 credits™. This group of talks has a single post-test, which must be completed along with an evaluation form to obtain credit. The links to the post-test appear on the individual talk pages.
Date of Web Release: February 15, 2006
CME Credit Eligible Through: April 30, 2007
AMA PRA Category 1 Credits™: 2.0
Target Audiences: Nephrology Board and Recertification candidates practicing nephrologists and internists.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

STATEMENT OF NEED :
Chronic kidney disease affects 30-40 million Americans, of whom several thousand require renal replacement therapy. These selected lectures are chosen by the HDCN editor and ASN Postgraduate Medical Director to reflect those areas of practice of greatest interest to the clinician, and areas where recent progress has occurred. The web extension of these ASN lectures will allow nephrologists and other physicians who were unable to attend the live sessions to gain similar benefit from these presentations.
ACCREDITATION STATEMENT:
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The ASN designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The American Medical Association has determined that non-US licensed physicians who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

SPONSORSHIP / SUPPORT :
This official ASN symposium was supported by a restricted educational grant from Watson Pharmaceuticals, Inc.

FACULTY DISCLOSURE STATEMENTS :
American Society of Nephrology as well as HDCN have conflict of interest policies that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants. Speaker disclosures are posted on each individual talk page.
DISCLOSURE OF UNLABELED USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Speaker disclosure about individual talks is posted on each individual talk page.

DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

USER INSTRUCTIONS:
To complete this educational activity, the user will need Windows or Macintosh operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or the Real Player from Real Media (www.real.com) is required and either can be downloaded for free per instructions on the individual lecture pages. Flash version 8.0 is required for the full-screen slide version of the program. Acrobat Reader is required to print the CME certificate, and this can be download free from www.adobe.com.

For any questions concerning this specific activity please send an email to or email@asn-online.org, or call HDCN at 630-325-3276.

For any general questions concerning ASN CME, please contact the American Society of Nephrology.